MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?

MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?

MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of bi...

Full description

Bibliographic Details
Main Authors: A. Gomez-Iturriaga, D. Büchser, I. San Miguel, M. Marban, A. Urresola, A. Ezquerro, A. Gil, F. Suarez, A. Gonzalez, E. Mairata, L. Martinez-Indart, J. Cacicedo, F. Couñago, P. Mínguez, F. Casquero
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Prostate cancer
Radiotherapy
Multiparametric MRI
Extraprostatic extension
Biochemical failure
Metastases
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630820300689
id doaj-600dde2f11414d31990be60fe4765883
record_format Article
spelling doaj-600dde2f11414d31990be60fe47658832021-06-02T13:26:53ZengElsevierClinical and Translational Radiation Oncology2405-63082020-09-0124135139MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?A. Gomez-Iturriaga0D. Büchser1I. San Miguel2M. Marban3A. Urresola4A. Ezquerro5A. Gil6F. Suarez7A. Gonzalez8E. Mairata9L. Martinez-Indart10J. Cacicedo11F. Couñago12P. Mínguez13F. Casquero14Hospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, Spain; Corresponding author at: Department of Radiation Oncology, Hospital Universitario Cruces, Plaza Cruces Gurutzeta 12, 48903 Barakaldo, Spain.Hospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, Spain; Hospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Health Research Institute, Clinical Epidemiology Unit, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainDepartment of Radiation Oncology, Hospital Universitario Quirón salud Madrid, 28223 Pozuelo de Alarcón, Madrid, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainMRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases.http://www.sciencedirect.com/science/article/pii/S2405630820300689Prostate cancerRadiotherapyMultiparametric MRIExtraprostatic extensionBiochemical failureMetastases
collection DOAJ
language English
format Article
sources DOAJ
author A. Gomez-Iturriaga
D. Büchser
I. San Miguel
M. Marban
A. Urresola
A. Ezquerro
A. Gil
F. Suarez
A. Gonzalez
E. Mairata
L. Martinez-Indart
J. Cacicedo
F. Couñago
P. Mínguez
F. Casquero
spellingShingle A. Gomez-Iturriaga
D. Büchser
I. San Miguel
M. Marban
A. Urresola
A. Ezquerro
A. Gil
F. Suarez
A. Gonzalez
E. Mairata
L. Martinez-Indart
J. Cacicedo
F. Couñago
P. Mínguez
F. Casquero
MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
Clinical and Translational Radiation Oncology
Prostate cancer
Radiotherapy
Multiparametric MRI
Extraprostatic extension
Biochemical failure
Metastases
author_facet A. Gomez-Iturriaga
D. Büchser
I. San Miguel
M. Marban
A. Urresola
A. Ezquerro
A. Gil
F. Suarez
A. Gonzalez
E. Mairata
L. Martinez-Indart
J. Cacicedo
F. Couñago
P. Mínguez
F. Casquero
author_sort A. Gomez-Iturriaga
title MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
title_short MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
title_full MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
title_fullStr MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
title_full_unstemmed MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
title_sort mri detected extaprostatic extension (epe) in prostate cancer: do all t3a patients have the same outcomes?
publisher Elsevier
series Clinical and Translational Radiation Oncology
issn 2405-6308
publishDate 2020-09-01
description MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases.
topic Prostate cancer
Radiotherapy
Multiparametric MRI
Extraprostatic extension
Biochemical failure
Metastases
url http://www.sciencedirect.com/science/article/pii/S2405630820300689
work_keys_str_mv AT agomeziturriaga mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT dbuchser mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT isanmiguel mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT mmarban mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT aurresola mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT aezquerro mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT agil mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT fsuarez mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT agonzalez mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT emairata mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT lmartinezindart mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT jcacicedo mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT fcounago mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT pminguez mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
AT fcasquero mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes
_version_ 1721403958128279552

Similar Items